GlioCART GmbH
PrivateLast Round
Seed
Nov 17, 2025
Total Funding Raised
$250,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GlioCART GmbH is a biotechnology company developing a dual-action CAR-T cell therapy for glioblastoma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GlioCART GmbH Comparables
Compare GlioCART GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chimeric Therapeutics Limited | 76% | |
| Siren Biotechnology | 75% | |
| Century Therapeutics | 73% |
GlioCART GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 17, 2025 |
Key People
Founding team and executive leadership
GlioCART GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Basel | Grant |
| Venture Kick | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 17, 2025
$190K round led by Venture Kick
GlioCART GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access